Abstract 1888: The FAD-directed LSD1 specific inhibitor, INCB059872, is a promising epigenetic agent for AML therapy by inducing differentiation of leukemic stem/progenitor cells
暂无分享,去创建一个
P. Scherle | B. Ruggeri | M. Ye | Sang Hyun Lee | G. Hollis | S. Yeleswaram | W. Yao | Chunhong He | A. Chadderton | Liangxing Wu | R. Huber | M. Diamond | A. Roberts | Michael Weber | V. Roman